Decarbonization Plus Acquisition Corporation IV (the "Company") announced today that it has commenced its initial public offering ("IPO") of 27,500,000 units at a price of $10.00 per unit. The Company
Hotel-deal booking specialists HotelPlanner and Reservations.com are close to signing a merger deal and go public via Astrea Acquisition Corp (NASDAQ: ASAX), a special purpose acquisition company, The Wall Street Journal
Roth Capital initiated coverage of Unicycive Therapeutics (NASDAQ:UNCY) with a Buy rating and $13.50 price target. Analyst Elemer Piros says that the Company could submit…
Leafly Holdings Inc. ("Leafly"), the world's leading online cannabis discovery marketplace and resource for cannabis consumers, and Merida Merger Corp. I (NASDAQ:MCMJ) ("Merida"), a special
With the start of a new week comes the excitement surrounding a new set of companies looking to make an impact through their public offerings. According to Benzinga Pro, these enticing companies are scheduled to trade publicly this week.
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific moves, while clinical readouts also moved stocks during the week.
The months of June and July were among the busiest for SPAC merger votes so far in 2021. August is now filling up with several deal votes happening each week.
Many of the July merger votes acted as catalysts with shares seeing sharp increases or decreases on their last few days trading under the old ticker and first days under the new ticker.
CM Life Sciences III Inc (NASDAQ: CMLT), the third SPAC backed by Eli Casdin’s Casdin Capital LLC and Keith Meister’s Corvex Management LP, is set to merge with EQRx Inc (NASDAQ: EQRX).
The stock will list on NASDAQ under the EQRX symbol.